0
Skip to Content
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data
BLOODPAC Portal
BLOODPAC Data Commons
Impact
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Events
Resources
BLOODPAC Governance
Insights
Videos
MEMBER LOGIN
BLOODPAC
BLOODPAC
About
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Approach
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Data
BLOODPAC Portal
BLOODPAC Data Commons
Impact
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Events
Resources
BLOODPAC Governance
Insights
Videos
MEMBER LOGIN
Folder: About
Back
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Folder: Approach
Back
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Folder: Data
Back
BLOODPAC Portal
BLOODPAC Data Commons
Folder: Impact
Back
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Events
Folder: Resources
Back
BLOODPAC Governance
Insights
Videos
MEMBER LOGIN
Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons
Cheyenne Jankiewicz 4/23/25 Cheyenne Jankiewicz 4/23/25

Recommended Clinical Context and Patient Context Data Elements for Liquid Biopsy Data Submitted to Data Repositories and Data Commons

Read More
Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-based Tests for Early Cancer Detection
Cheyenne Jankiewicz 4/21/25 Cheyenne Jankiewicz 4/21/25

Navigating Complexity: Perspectives on Risk Assessment in the Era of New Blood-based Tests for Early Cancer Detection

Read More
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium
Guest User 3/14/25 Guest User 3/14/25

Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium

Read More
Lexicon for blood-based early detection and screening:  BLOODPAC consensus document
Guest User 8/29/24 Guest User 8/29/24

Lexicon for blood-based early detection and screening: BLOODPAC consensus document

Read More
Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis
Guest User 8/23/24 Guest User 8/23/24

Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis

Read More
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care
Guest User 1/2/24 Guest User 1/2/24

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care

Read More
Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests
Lauren Leiman 2/22/23 Lauren Leiman 2/22/23

Contrived Materials and a Data Set for the Evaluation of Liquid Biopsy Tests

Read More
BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection
Lauren Leiman 10/17/22 Lauren Leiman 10/17/22

BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection

Read More
Creating Standards for Liquid Biopsies: the BLOODPAC Experience
Lauren Leiman 8/10/22 Lauren Leiman 8/10/22

Creating Standards for Liquid Biopsies: the BLOODPAC Experience

Read More
The BloodPAC Data Commons for Liquid Biopsy Data
Laura Tramontozzi 4/21/21 Laura Tramontozzi 4/21/21

The BloodPAC Data Commons for Liquid Biopsy Data

Read More
FDA-Reviewed Validation Protocols for Liquid Biopsy
News Laura Tramontozzi 9/2/20 News Laura Tramontozzi 9/2/20

FDA-Reviewed Validation Protocols for Liquid Biopsy

Read More
Three types of COVID-19 tests needed for return to normalcy</a>
News Laura Tramontozzi 4/9/20 News Laura Tramontozzi 4/9/20

Three types of COVID-19 tests needed for return to normalcy

Read More
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases
Laura Tramontozzi 4/1/20 Laura Tramontozzi 4/1/20

Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases

Read More
Getting past the bad blood of Theranos through collaboration</a>
News Laura Tramontozzi 3/16/18 News Laura Tramontozzi 3/16/18

Getting past the bad blood of Theranos through collaboration

Read More
Initial Release of Open Data
News Laura Tramontozzi 2/12/18 News Laura Tramontozzi 2/12/18

Initial Release of Open Data

Read More

ABOUT

BLOODPAC is a consortium managed by the Center for Computational Science Research, Inc. (CCSR), which is an Illinois based 501 (c)(3) not-for-profit corporation. Our mission is to accelerate the development, validation, and accessibility of liquid biopsy assays to improve outcomes for patients with cancer. To do so, we lead a pre-competitive collaborative infrastructure that enables the sharing of information and building of consensus among stakeholders in industry, academia, regulatory bodies, payers, and government agencies.